Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Loudos

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Nuclear Medicine and Biology|December 15, 2012
Biological evaluation of an ornithine-modified (99m)Tc-labeled RGD peptide as an angiogenesis imaging agentIrene Tsiapa, George Loudos, Alexandra Varvarigou, et al.
Journal of Medicinal Chemistry|June 16, 2009
Structural assessment and biological evaluation of two N3S bombesin derivativesEleni Gourni, Penelope Bouziotis, Dimitra Benaki, et al.
American Journal of Nephrology|September 12, 2012
Parstatin prevents renal injury following ischemia/reperfusion and radiocontrast administrationAthanasios Diamantopoulos, Iason Kyriazis, Katerina Geronatsiou, et al.
International Journal of Pharmaceutics|March 31, 2012
Structural modifications of ⁹⁹mTc-labelled bombesin-like peptides for optimizing pharmacokinetics in prostate tumor targetingChristos C Liolios, Eirini A Fragogeorgi, Christos Zikos, et al.
International Journal of Nanomedicine|July 17, 2014
In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticlesGiovanni Baldi, Costanza Ravagli, Filippo Mazzantini, et al.
Journal of Medicinal Chemistry|June 4, 2010
Evaluation of Re and (99m)Tc complexes of 2-(4'-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticalsStamatia Tzanopoulou, Marina Sagnou, Maria Paravatou-Petsotas, et al.
International Journal of Pharmaceutics|March 4, 2014
Comparative in vitro stability and scintigraphic imaging for trafficking and tumor targeting of a directly and a novel ⁹⁹mTc(I)(CO)₃ labeled liposomeEirini A Fragogeorgi, Irina N Savina, Theodoros Tsotakos, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 19, 2014
Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivoIrene Tsiapa, George Loudos, Eirini A Fragogeorgi, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 15, 2017
In vivo biodistribution and imaging studies with a <sup>99m</sup>Tc-radiolabeled derivative of the C-terminus of prothymosin alpha in mice bearing experimentally-induced inflammationChrysoula-Evangelia Karachaliou, Charalampos Triantis, Christos Liolios, et al.
Pharmaceutics|March 29, 2023
[<sup>111</sup>In]In/[<sup>177</sup>Lu]Lu-AAZTA<sup>5</sup>-LM4 SST<sub>2</sub>R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient ResultsBerthold A Nock, Panagiotis Kanellopoulos, Euy Sung Moon, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Nuclear Medicine and Biology|December 15, 2012
Biological evaluation of an ornithine-modified (99m)Tc-labeled RGD peptide as an angiogenesis imaging agentIrene Tsiapa, George Loudos, Alexandra Varvarigou, et al.
Journal of Medicinal Chemistry|June 16, 2009
Structural assessment and biological evaluation of two N3S bombesin derivativesEleni Gourni, Penelope Bouziotis, Dimitra Benaki, et al.
American Journal of Nephrology|September 12, 2012
Parstatin prevents renal injury following ischemia/reperfusion and radiocontrast administrationAthanasios Diamantopoulos, Iason Kyriazis, Katerina Geronatsiou, et al.
International Journal of Pharmaceutics|March 31, 2012
Structural modifications of ⁹⁹mTc-labelled bombesin-like peptides for optimizing pharmacokinetics in prostate tumor targetingChristos C Liolios, Eirini A Fragogeorgi, Christos Zikos, et al.
International Journal of Nanomedicine|July 17, 2014
In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticlesGiovanni Baldi, Costanza Ravagli, Filippo Mazzantini, et al.
Journal of Medicinal Chemistry|June 4, 2010
Evaluation of Re and (99m)Tc complexes of 2-(4'-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticalsStamatia Tzanopoulou, Marina Sagnou, Maria Paravatou-Petsotas, et al.
International Journal of Pharmaceutics|March 4, 2014
Comparative in vitro stability and scintigraphic imaging for trafficking and tumor targeting of a directly and a novel ⁹⁹mTc(I)(CO)₃ labeled liposomeEirini A Fragogeorgi, Irina N Savina, Theodoros Tsotakos, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 19, 2014
Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivoIrene Tsiapa, George Loudos, Eirini A Fragogeorgi, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 15, 2017
In vivo biodistribution and imaging studies with a <sup>99m</sup>Tc-radiolabeled derivative of the C-terminus of prothymosin alpha in mice bearing experimentally-induced inflammationChrysoula-Evangelia Karachaliou, Charalampos Triantis, Christos Liolios, et al.
Pharmaceutics|March 29, 2023
[<sup>111</sup>In]In/[<sup>177</sup>Lu]Lu-AAZTA<sup>5</sup>-LM4 SST<sub>2</sub>R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient ResultsBerthold A Nock, Panagiotis Kanellopoulos, Euy Sung Moon, et al.
Pageof 9